We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pair of Enhanced Techniques Developed for Stem Cell Lineage Tracing

By LabMedica International staff writers
Posted on 21 Jun 2016
European cell biologists have developed a pair of methods for the precise assessment of the multipotent or unipotent fate of stem cells.

Lineage tracing has become the method of choice to study the fate and dynamics of stem cells (SCs) during development, homeostasis, and regeneration. More...
In order to increase the tools available for lineage tracing, investigators at the Université libre de Bruxelles (Belgium) developed two novel methods to determine whether stem cells in the mammary gland and in the prostate were multipotent or unipotent during development and adult maintenance.

They described the two methods in the June 9, 2016, online edition of the journal Genes & Development. The first one was based on statistical analysis of multicolor lineage tracing, allowing the definition of multipotency potential to be achieved with high confidence, and the second one was based on lineage tracing at saturation to assess the fate of all SCs within a given lineage and the “flux” of cells between different lineages.

Analysis clearly revealed that, whereas the prostate developed from multipotent SCs, only unipotent SCs mediated mammary gland (MG) development and adult tissue remodeling.

"These methods offer a rigorous framework to assess the lineage relationship and stem cell fate in different organs and tissues. These techniques will become the new standard to decipher the lineage relationship in many other organs or tissues during development, tissue repair and tumor initiation," said senior author Dr. Cédric Blanpain, professor of stem cell and development biology at the Université libre de Bruxelles.

Related Links:
Université libre de Bruxelles



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.